Open AccessS168: ERYTHROPOIETIN STIMULATION AGENTS SIGNIFICANTLY IMPROVES OUTCOME IN LOWER RISK MDS.
Author(s) -
Garelius H.,
Smith A.,
Bagguley T.,
Taylor A.,
Fenaux P.,
Bowen D.,
Symeonidis A.,
Mittelmann M.,
Stauder R.,
Čermák J.,
Sanz G.,
Langemeijer S.,
Malcovati L.,
Germing U.,
Itzykson R.,
GuerciBresler A.,
Culligan D.,
Kotsianidis I.,
Koinig Mag K.,
Marrewijk C.,
Crouch S.,
Witte T.,
HellströmLindberg E.
Publication year - 2022
Publication title -
hemasphere
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000843564.40783.b4
Subject(s) - medicine , propensity score matching , quality of life (healthcare) , erythropoietin , confounding , confidence interval , intensive care medicine , emergency medicine , pediatrics , nursing